134 related articles for article (PubMed ID: 16794828)
1. Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.
Jinawath A; Akiyama Y; Yuasa Y; Pairojkul C
J Cancer Res Clin Oncol; 2006 Dec; 132(12):805-10. PubMed ID: 16794828
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
[TBL] [Abstract][Full Text] [Related]
3. Intraductal growth-type mucin-producing peripheral cholangiocarcinoma associated with biliary papillomatosis.
Güllüoglu MG; Ozden I; Poyanli A; Cevikbas U; Ariogul O
Ann Diagn Pathol; 2007 Feb; 11(1):34-8. PubMed ID: 17240305
[TBL] [Abstract][Full Text] [Related]
4. Expression of homeodomain protein CDX2 in gallbladder carcinomas.
Wu XS; Akiyama Y; Igari T; Kawamura T; Hiranuma S; Shibata T; Tsuruta K; Koike M; Arii S; Yuasa Y
J Cancer Res Clin Oncol; 2005 May; 131(5):271-8. PubMed ID: 15645288
[TBL] [Abstract][Full Text] [Related]
5. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
7. Tumorigenesis and phenotypic characteristics of mucin-producing bile duct tumors: an immunohistochemical approach.
Nakanuma Y; Zen Y; Harada K; Ikeda H; Sato Y; Uehara T; Sasaki M
J Hepatobiliary Pancreat Sci; 2010 May; 17(3):211-22. PubMed ID: 19680592
[TBL] [Abstract][Full Text] [Related]
8. Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.
Sasaki M; Nitta T; Sato Y; Nakanuma Y
Hum Pathol; 2015 Feb; 46(2):202-9. PubMed ID: 25466963
[TBL] [Abstract][Full Text] [Related]
9. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
10. CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma.
Hong SM; Cho H; Moskaluk CA; Frierson HF; Yu E; Ro JY
Am J Clin Pathol; 2005 Sep; 124(3):361-70. PubMed ID: 16191504
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
12. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Histopathology; 2006 Jul; 49(1):35-44. PubMed ID: 16842244
[TBL] [Abstract][Full Text] [Related]
14. Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment.
Dokduang H; Juntana S; Techasen A; Namwat N; Yongvanit P; Khuntikeo N; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3519-28. PubMed ID: 23812726
[TBL] [Abstract][Full Text] [Related]
15. Intraductal papillary neoplasm of the bile duct associated with Clonorchis sinensis infection.
Jang KT; Hong SM; Lee KT; Lee JG; Choi SH; Heo JS; Choi DW; Choi D; Lim JH
Virchows Arch; 2008 Dec; 453(6):589-98. PubMed ID: 18855009
[TBL] [Abstract][Full Text] [Related]
16. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
[TBL] [Abstract][Full Text] [Related]
18. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
[TBL] [Abstract][Full Text] [Related]
19. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
